Not applicableUnknownNCT04972591What this trial is testingFollow-up Study of Population Vaccinated With COVID-19 VaccineWho this might be right forHealthy Qin Ning 1,000
Early research (Phase 1)Not Yet RecruitingNCT07640308What this trial is testingBio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine BoosterWho this might be right forSevere Acute Respiratory Syndrome (SARS-CoV-2 Virus) The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 90
Testing effectiveness (Phase 2)UnknownNCT05939648What this trial is testingA Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)Who this might be right forSARS-CoV-2 AIM Vaccine Co., Ltd. 450
Post-approval studies (Phase 4)UnknownNCT05157178What this trial is testingImmunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.Who this might be right forCOVID-19 The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,264
Testing effectiveness (Phase 2)Study completedNCT04695652What this trial is testingEvaluate MVC-COV1901 Vaccine Against COVID-19 in AdultWho this might be right forCovid19 Vaccine Medigen Vaccine Biologics Corp. 3,854
Testing effectiveness (Phase 2)Study completedNCT05411471What this trial is testingImmunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron StrainWho this might be right forCOVID-19 Sinovac Biotech (Hong Kong) Limited 221
Not applicableStudy completedNCT05124509What this trial is testingImmune Response to Third Dose of COVID-19 Vaccine in Solid Organ TransplantWho this might be right forCOVID-19SARS-CoV-2 InfectionSolid Organ Transplant+1 more Pontificia Universidad Catolica de Chile 147
Testing effectiveness (Phase 2)Study completedNCT04742738What this trial is testingSafety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)Who this might be right forCOVID-19 (Healthy Volunteers) SK Bioscience Co., Ltd. 260
Not applicableActive Not RecruitingNCT04798625What this trial is testingVaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive MedicationWho this might be right forRheumatoid ArthritisPsoriatic ArthritisSpondyloarthritis+4 more Diakonhjemmet Hospital 2,300
Not applicableStudy completedNCT05121662What this trial is testingCOVID-19 Vaccine Biomarker Study in Multiple SclerosisWho this might be right forMultiple SclerosisCOVID-19 Columbia University 154
Early research (Phase 1)Study completedNCT05233826What this trial is testingSafety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19Who this might be right forCOVID-19SARS-CoV-2 Codagenix, Inc 20
Testing effectiveness (Phase 2)Study completedNCT04383574What this trial is testingSafety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)Who this might be right forCOVID-19 Sinovac Life Sciences Co., Ltd. 422
Not applicableStudy completedNCT05857176What this trial is testingAssessment of Safety and Satisfaction Toward COVID-19 Vaccines.Who this might be right forCOVID-19 Vaccine Adverse Reaction Damanhour University 508
Testing effectiveness (Phase 2)Study completedNCT04436276What this trial is testingAd26.COV2.S in Adults (COVID-19)Who this might be right forCovid-19 Prevention Janssen Vaccines & Prevention B.V. 1,085
Very early researchNot Yet RecruitingNCT06768697What this trial is testingSafety and Immunogenicity Evaluation of the Recombinant Flagellin Protein AdjuvantWho this might be right forCOVID - 19 Shanghai Public Health Clinical Center 60
Not applicableStudy completedNCT05933304What this trial is testingThe Effectiveness of Moderna COVID-19 VaccineWho this might be right forSARS-CoV-2COVID-19 ModernaTX, Inc. 927,004
Testing effectiveness (Phase 2)Active Not RecruitingNCT06672055What this trial is testingEvaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 InfectionWho this might be right forSARS-CoV2COVID-19 Vaxart 5,485
Large-scale testing (Phase 3)UnknownNCT05749926What this trial is testingImmunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA VaccineWho this might be right forVaccine ReactionCOVID-19 Assistance Publique - Hôpitaux de Paris 248
Post-approval studies (Phase 4)UnknownNCT05329038What this trial is testingImmunogenicity,Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 VaccineWho this might be right forCOVID-19 Sinovac Life Sciences Co., Ltd. 180
Not applicableStudy completedNCT04954651What this trial is testingAssessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 VaccinesWho this might be right forSARS-CoV2 InfectionVaccine Reaction University of Patras 1,000